Dabigatran at 72 Hours Effective for Patients With Acute Intermediate-Risk Pulmonary Embolism
Researchers sought to determine whether early dabigatran would be effective and safe in patients with acute intermediate-risk pulmonary embolism.
Pulmonary Embolism
Early Central Venous Catheter Removal and Pulmonary Embolism Risk
Researchers sought to determine whether early central venous catheter removal would be linked to pulmonary embolism risk in patients with catheter-related upper extremity deep vein thrombosis.
Thromboembolic Disorders: Treatments
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
Anticoagulation Ineffective for Patients With Isolated Distal Deep Vein Thrombosis
Researchers sought to determine whether anticoagulation would be effective at preventing PE for patients with id-DVT.
No Difference in Venous Thromboembolism Based on Venous Injury Treatment With Repair or Ligation
Researchers sought to determine whether there was a difference between venous repairs or ligation in rates of DVT or PE in patients with lower extremity venous injury.
von Willebrand Factor Plasma Levels May Affect Future Venous Thromboembolism Risk
A population-based analysis suggested that plasma levels of von Willebrand factor may be a potential biomarker for the future risk of incident venous thromboembolism.
Notable Variation Exists in the Treatment of Serious VTE Events in Pediatric Leukemia
There might be notable variations among hematology, oncology, and bone marrow transplant practitioners when treating thrombotic events in children with leukemia.
ASH 2020 Guidelines on Venous Thromboembolism Management
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Diagnosis and Treatment of Pulmonary Embolism in Patients With COVID-19
A position paper recently published by the National Pulmonary Embolism Response Team outlines an approach for diagnosing and treating pulmonary embolism in patients with COVID-19.
Deep Vein Thrombosis Incidence and Pulmonary Embolism Risk Stratification
High or intermediate PE risk status was linked with lower rates of DVT, but asymptomatic DVT was more often found with high or intermediate PE risk.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...